Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Post by DrHolidayon Jun 14, 2018 5:11pm
122 Views
Post# 28174679

Sellers beware of news!

Sellers beware of news!If you've shorted millions of shares at very low prices, then you must ask yourself just how much you are prepared to lose if you don't cover the position by offsetting the short with corresponding buy orders. If you fail to do this before the big news is released by ICO then there is no limiting your losses when the stock rockets into the stratosphere. At 50 cents, your short uncovered would yield roughly 10 fold losses, and then when you are forced to cover, your short covering would force the stock even higher than that.

So do us a favor, and don't cover until the news is out, then you will be forced to cover and change your soiled shorts because when big institutional buy orders kick in from buyside analyst reccomendations, ICO will go parabolic. The international marketing rights to Oral B Amphotericin are another bullish catalyst from distributors that want ICO to produce and supply as per each contract. I believe the cost of Oral B Amphotericin will be significantly lower than the injectable dose and garner a huge share of the existing market which is many billions per year. Seller beware.
<< Previous
Bullboard Posts
Next >>